All stock lists
Nuveen Pennsylvania Quality Municipal Income Fund (New York Stock Exchange:NQP)
US · Delayed Price · Currency is USD
Financial Services · Asset Management
$12.03+$0.01 (+0.08%)
Market cap
$448M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 21, 1991
Website
Insider Score
––Not scored
NQP Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From NQP’s reported statements · Q3 2025 (trailing 12 months)
Profitability9 / 20
Loses money on what it sells.
- Revenue
- $69.0M
- Net income
- -$1.7M
- Net margin
- -2.4%
Leverage0 / 20
Heavily indebted for what it earns.
- Total debt
- $327.5M
- Cash
- $0
- Net debt / EBITDA
- 69.69x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $31.3M
- Current liabilities
- $3.6M
- Current ratio
- 8.57
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $24.8M
- Free cash flow
- $24.8M
- FCF margin
- 35.9%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 37.2M
- Share growth (1y)
- 0.0%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
NQP Income Statement
| Fiscal Period | Q3 2025 | Q3 2025 | Q3 2024 | Q3 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|
| Period Ending | Aug 31, 2025 | Aug 31, 2025 | Aug 31, 2024 | Aug 31, 2024 | Feb 29, 2024 | Aug 31, 2023 |
| Revenue | $22.80 M | $14.50 M | $21.00 M | $10.66 M | $15.95 M | $15.70 M |
| Revenue Growth (YoY) | 42.93 % | -7.65 % | 32.18 % | -28.16 % | 1.66 % | -4.38 % |
| Cost of Revenue | $2.45 M | $2.38 M | $2.51 M | -$2.51 M | $0.00 | -$4.86 M |
| Gross Profit | $20.35 M | $12.12 M | $18.49 M | $13.17 M | $15.95 M | $20.56 M |
| SG&A Expense | $0.00 | $0.00 | -$4.89 M | $10.05 M | $2.55 M | -$2.20 M |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $21.75 M | $32.56 M | -$4.89 M | $10.05 M | $2.55 M | $2.61 M |
| Operating Income | -$1.40 M | -$20.43 M | $23.38 M | $3.11 M | $13.40 M | $13.09 M |
| Pretax Income | -$7.78 M | -$26.45 M | $16.31 M | $16.24 M | $33.02 M | -$470.37 K |
| Tax Provision | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$7.78 M | -$26.45 M | $16.31 M | $16.24 M | $33.02 M | -$470.37 K |
| EPS (Basic) | -$0.21 | -$0.71 | $0.44 | $0.43 | $0.89 | -$0.02 |
| EPS (Diluted) | -$0.21 | -$0.71 | $0.44 | $0.43 | $0.89 | -$0.02 |
| Shares Outstanding | 37.22 M | 37.22 M | 37.22 M | 37.22 M | 37.21 M | 37.21 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.